.After announcing a period 3 launch based on favorable midstage end results, iTeos and GSK are actua...
.The FDA ought to be more available as well as joint to unleash a surge in commendations of rare ail...
.It's an extraordinarily occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicar...
.Atea Pharmaceuticals' antiviral has fallen short one more COVID-19 test, yet the biotech still keep...
.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was ac...
.Sanofi has actually created a late access to the radioligand gathering, paying out one hundred mill...
.After F2G's initial try to obtain a brand-new course of antifungal to market was derailed by the FD...
.Moderna has actually sworn to reduce R&D costs through $1.1 billion through 2027. The decision t...
.Just four months after Sanofi bet $80 thousand in beforehand money on Fulcrum Rehabs' losmapimod, t...
.Cancer provider Oncternal Rehabs is folding all its professional trials and also laying off team, t...